Case number: 2:19-bk-13902 - Immune Pharmaceuticals USA Corporation - New Jersey Bankruptcy Court

Case Information
  • Case title

    Immune Pharmaceuticals USA Corporation

  • Court

    New Jersey (njbke)

  • Chapter

    7

  • Judge

    Vincent F. Papalia

  • Filed

    02/26/2019

  • Last Filing

    10/22/2024

  • Asset

    Yes

  • Vol

    v

Docket Header
JNTADMN



U.S. Bankruptcy Court
District of New Jersey (Newark)
Bankruptcy Petition #: 19-13902-VFP

Assigned to: Judge Vincent F. Papalia
Chapter 11
Voluntary
Asset


Date filed:  02/26/2019
341 meeting:  04/17/2019
Deadline for filing claims:  07/16/2019

Debtor

Immune Pharmaceuticals USA Corporation

1 Bridge Plaza North
Suite 270
Fort Lee, NJ 07024
BERGEN-NJ
Tax ID / EIN: 27-1139630
represented by
Morris S. Bauer

Norris McLaughlin & Marcus, PA
400 Crossing Boulevard
8th Floor
Bridgewater, NJ 08807
908-252-4345
Email: msbauer@nmmlaw.com

U.S. Trustee

U.S. Trustee

US Dept of Justice
Office of the US Trustee
One Newark Center Ste 2100
Newark, NJ 07102
(973) 645-3014
 
 

Latest Dockets

Date Filed#Docket Text
09/05/201926Monthly Operating Report for Filing Period July, 2017 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
09/05/201925Monthly Operating Report for Filing Period June, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
09/05/201924Monthly Operating Report for Filing Period May, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
09/05/201923Monthly Operating Report for Filing Period April, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
09/05/201922Monthly Operating Report for Filing Period February, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 09/05/2019)
05/17/201921BNC Certificate of Notice - Order No. of Notices: 1. Notice Date 05/17/2019. (Admin.) (Entered: 05/18/2019)
05/17/201920Certificate of Service (related document: 18 Order Respecting Amendment to Schedule(s)) filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 05/17/2019)
05/15/201919Monthly Operating Report for Filing Period March, 2019 filed by Morris S. Bauer on behalf of Immune Pharmaceuticals USA Corporation. (Bauer, Morris) (Entered: 05/15/2019)
05/15/201918Order Respecting Amendment to Schedule(s) (related document: 17 Amended Schedules (Fee Attorney) filed by Debtor Immune Pharmaceuticals USA Corporation). Service of notice of the entry of this order pursuant to Rule 9022 was made on the appropriate parties. See BNC Certificate of Notice. Signed on 5/15/2019. (ntp) (Entered: 05/15/2019)
04/17/2019Receipt of filing fee for Amended Schedules (Fee Attorney)( 19-13902-VFP) [misc,amdsch3a] ( 31.00) Filing Fee. Receipt number A38612611, fee amount $ 31.00. (re: Doc# 17) (U.S. Treasury) (Entered: 04/17/2019)